https://www.zacks.com/stock/news/2227473/company-news-for-feb-16-2024?cid=CS-ZC-FT-corporate_summary-2227473
Feb 16, 2024 - Companies in The News Are:HBI,WEN,ET,CF
zc:7092769057628201414
0
https://www.zacks.com/stock/news/2226492/cf-cf-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2226492
Feb 14, 2024 - While the top- and bottom-line numbers for CF (CF) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:1332261986309812116
0
https://www.zacks.com/stock/news/2224005/insights-into-cf-cf-q4-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224005
Feb 09, 2024 - Evaluate the expected performance of CF (CF) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
zc:-4904919434498953248
0
https://seekingalpha.com/news/4062897-vertex-to-seek-fda-ema-approval-for-vanza-triple-therapy-for-cf?source=feed_sector_healthcare
Feb 05, 2024 - Vertex Pharmaceuticals (VRTX) reported positive Phase 3 study results for its vanza triple therapy in the treatment of cystic fibrosis and plans to seek US and
0
sa:-3436292191452051880
0
https://seekingalpha.com/news/4057428-4d-molecular-gets-fda-rare-pediatric-disease-status-for-cf-drug?source=feed_sector_healthcare
Jan 23, 2024 - 4D Molecular Therapeutics (FDMT) has received FDA rare pediatric disease designation for its cystic fibrosis drug candidate 4D-710. Read more here.
0
sa:2890690695634487798
0
https://www.zacks.com/stock/news/2214329/focus-on-these-4-low-p-cf-stocks-to-maximize-returns-in-2024?cid=CS-ZC-FT-analyst_blog|rw-2214329
Jan 23, 2024 - Value investing is essentially about selecting stocks that are cheap but fundamentally sound. PVH Corp. (PVH), Centene (CNC), General Motors (GM) and Graphic Packaging (GPK) boast a low P/CF ratio.
zc:7401236223959975111
0
https://www.zacks.com/stock/news/2206869/zacks-industry-outlook-highlights-cf-industries-and-icl?cid=CS-ZC-FT-press_releases-2206869
Jan 08, 2024 - CF Industries and ICL are part of the Zacks Industry Outlook article.
zc:7182716660624843138
0
https://www.zacks.com/commentary/2206027/2-fertilizer-stocks-to-watch-amid-industry-headwinds?cid=CS-ZC-FT-industry_outlook-2206027
Jan 05, 2024 - A pullback in fertilizer prices on softer demand and elevated costs of key raw materials pose headwinds for the Zacks Fertilizers industry. CF and ICL are poised well to tackle the challenges.
zc:-241901655187212765
0
https://www.zacks.com/stock/news/2192829/add-value-to-your-investment-with-these-4-low-p-cf-stocks?cid=CS-ZC-FT-analyst_blog|rw-2192829
Dec 04, 2023 - Value investing is essentially about selecting stocks that are cheap but fundamentally sound. PVH Corp. (PVH), Centene (CNC), Solo Brands (DTC) and Park Hotels & Resorts (PK) boast a low P/CF ratio.
zc:2225952468765878998
0